Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer

PURPOSE: Although adjuvant polychemotherapy improves outcomes for early breast cancer, the significant variability in terms of pharmacokinetics results in differences in efficacy and both short and long-term toxicities. Retrospective studies support the use of dose tailoring according to the hematol...

Descripción completa

Detalles Bibliográficos
Autores principales: Matikas, Alexios, Margolin, Sara, Hellström, Mats, Johansson, Hemming, Bengtsson, Nils-Olof, Karlsson, Lena, Edlund, Per, Karlsson, Per, Lidbrink, Elisabet, Linderholm, Barbro, Lindman, Henrik, Malmstrom, Per, Villman, Kenneth, Foukakis, Theodoros, Bergh, Jonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838137/
https://www.ncbi.nlm.nih.gov/pubmed/29190004
http://dx.doi.org/10.1007/s10549-017-4599-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838137/
https://www.ncbi.nlm.nih.gov/pubmed/29190004
http://dx.doi.org/10.1007/s10549-017-4599-4

Ejemplares similares